Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
43
|
pubmed:dateCreated |
1974-2-14
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0025-8512
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
26
|
pubmed:volume |
24
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1654-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:4764061-Dermatomyositis,
pubmed-meshheading:4764061-Humans,
pubmed-meshheading:4764061-Hydroxyproline,
pubmed-meshheading:4764061-Lupus Erythematosus, Systemic,
pubmed-meshheading:4764061-Middle Aged,
pubmed-meshheading:4764061-Pseudoxanthoma Elasticum,
pubmed-meshheading:4764061-Scleroderma, Systemic
|
pubmed:year |
1973
|
pubmed:articleTitle |
[Clinical significance of urinary hydroxyproline excretion].
|
pubmed:publicationType |
Journal Article
|